Other studies with retrospective follow-up of 13 to 14 years revealed a 90% reduction of breast cancer risk in women with BRCA1 and BRCA2 mutations who underwent bilateral total mastectomy [6, 33, 48]. The gene discussed is BRCA2; the disease is breast carcinoma.